Major adverse cardiovascular and limb events in people with diabetes treated with GLP-1 receptor agonists vs SGLT2 inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Major adverse cardiovascular and limb events in people with diabetes treated with GLP-1 receptor agonists vs SGLT2 inhibitors

Published:2022-08-09 Issue:12 Volume:65 Page:2032-2043
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Lin Donna Shu-Han,Yu An-Li,Lo Hao-Yun,Lien Cheng-Wei,Lee Jen-Kuang,Chen Wen-Jone

Funder

MOST

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00125-022-05772-9.pdf

Reference43 articles.

1. Fox CS, Golden SH, Anderson C et al (2015) Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: A scientific statement from the American Heart Association and the American Diabetes Association. Circulation 132:691–718. https://doi.org/10.1161/CIR.0000000000000230

2. Maranta F, Cianfanelli L, Cianflone D (2021) Glycaemic Control and Vascular Complications in Diabetes Mellitus Type 2. Adv Exp Med Biol 1307:129–152. https://doi.org/10.1007/5584_2020_514

3. Wilcox T, De Block C, Schwartzbard AZ, Newman JD (2020) Diabetic agents, from metformin to SGLT2 inhibitors and GLP1 receptor agonists: JACC Focus Seminar. J Am Coll Cardiol 75:1956–1974. https://doi.org/10.1016/j.jacc.2020.02.056

4. Colantonio LD, Hubbard D, Monda KL et al (2020) Atherosclerotic risk and statin use among patients with peripheral artery disease. J Am Coll Cardiol 76:251–264. https://doi.org/10.1016/j.jacc.2020.05.048

5. Criqui MH, Aboyans V (2015) Epidemiology of peripheral artery disease. Circ Res 116:1509–1526. https://doi.org/10.1161/CIRCRESAHA.116.303849

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of frailty on effectiveness and safety of GLP-1 receptor agonists versus SGLT2 inhibitors in people with type 2 diabetes in Taiwan: a retrospective, nationwide, longitudinal study;The Lancet Healthy Longevity;2024-09

2. Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and cerebrovascular diseases: a meta-analysis of controlled clinical trials;Frontiers in Endocrinology;2024-08-23

3. Incidence and progression of diabetic retinopathy in patients treated with glucagon‐like peptide‐1 receptor agonists versus sodium‐glucose cotransporter 2 inhibitors: A population‐based cohort study;Diabetes, Obesity and Metabolism;2024-07-19

4. Incretin‐based therapy and the risk of diabetic foot ulcers and related events;Diabetes, Obesity and Metabolism;2024-07

5. Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review;Cardiovascular Diabetology;2024-06-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3